Alembic Pharmaceuticals Limited has maintained a consistent and reliable history of rewarding its equity shareholders through regular annual dividend distributions. Financial records show a stable pattern of steady or growing payouts over the years, reflecting solid operational cash flows. Recent fiscal distributions include a final dividend of ₹11 per share, which subsequently increased to ₹12 per share. Prior fiscal years have similarly recorded dependable payouts ranging across ₹8 to ₹14 per share depending on annual financial performance and net profitability. These consistent disbursements demonstrate management's commitment to returning capital to investors while balancing heavy reinvestment into research and development, manufacturing facility upgrades, and global market expansion initiatives.